Background Researchers now have a new avenue to investigate when it comes to miRNA-
based therapeutics. miRNAs have the potential to be valuable biomarkers for disease …

Glioblastoma multiforme (GBM) is the most common and lethal cancer of the adult brain,
remaining incurable with a median survival time of only 15 months. In an effort to identify …

The degeneration and dysfunction of neurons are key features of neurodegenerative
diseases (NDs). Currently, one of the main challenges facing researchers and clinicians is …

Prolonged hypoxia, the event of insufficient oxygen, is known to upregulate tumor
development and growth by promoting the formation of a neoplastic environment. The recent …

Despite the wide research going on in Parkinson's disease (PD), the burden of PD still
remains high and continues to increase. The current drugs available for the treatment of PD …

Alzheimer's disease (AD) is the most common cause of senile dementia. Although AD
research has made important breakthroughs, the pathogenesis of this disease remains …

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa
damage associated with an uncontrolled inflammatory response. This immunological …

Autologous chimeric antigen receptor (CAR) T cells have recently emerged as potent tools
in the fight against cancer, with promising therapeutic efficacy against hematological …

MicroRNAs (miRNAs) are small, noncoding single-stranded RNA oligonucleotides that
modulate physiological and pathological processes by modulating target gene expression …

Multiple sclerosis (MS) is not only an autoimmune disease in which autoreactive immune
cells against myelin damage axons and nerves in the central nervous system, but also a …